Real-time Estimate Tradegate 08:36:55 2024-06-20 am EDT 5-day change 1st Jan Change
96.08 EUR -0.44% Intraday chart for Gerresheimer AG -7.04% +2.17%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
GERRESHEIMER AG : Jefferies keeps its Buy rating ZD
GERRESHEIMER AG : Deutsche Bank gives a Buy rating ZD
GERRESHEIMER AG : Jefferies remains its Buy rating ZD
Gerresheimer to Boost Production Capacity Via EUR166 Million US Expansion Project MT
GERRESHEIMER AG : DZ Bank remains its Buy rating ZD
GERRESHEIMER AG : Deutsche Bank keeps its Buy rating ZD
Hauck Aufhäuser IB raises Gerresheimer to 'Buy' - Target 122 euros DP
GERRESHEIMER AG : Raised to Buy by Hauck & Aufhauser ZD
JPMorgan rates Gerresheimer at 'Overweight' - Target 125.70 euros DP
GERRESHEIMER AG : JP Morgan reiterates its Buy rating ZD
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney... Our Logo
GERRESHEIMER AG : Receives a Buy rating from UBS ZD
GERRESHEIMER AG : Receives a Buy rating from Berenberg ZD
Gerresheimer with recovery rally - investors reward takeover DP
Gerresheimer expands pharma business with takeover DP
Gerresheimer Unit to Buy Pharmaceutical Packaging Company Bormioli Pharma in EUR800 Million Deal MT
Transcript : Blitz Luxco Sarl, Gerresheimer AG - M&A Call
Gerresheimer strong in pre-market trading - investors reward takeover DP
GERRESHEIMER AG : Jefferies maintains a Buy rating ZD
Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln RE
GERRESHEIMER AG : UBS reiterates its Buy rating ZD
Schott Pharma falls sharply - 'High dependence on end markets' DP
Schott Pharma warns of weak syringe sales - share price slide DP
GERRESHEIMER AG : Is no more a Sell but a Buy opportunity for UBS ZD
GERRESHEIMER AG : Buy rating from Barclays ZD
Chart Gerresheimer AG
More charts
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
96.5 EUR
Average target price
134.8 EUR
Spread / Average Target
+39.71%
Consensus
  1. Stock Market
  2. Equities
  3. GXI Stock
  4. News Gerresheimer AG
  5. Gerresheimer Unit to Buy Pharmaceutical Packaging Company Bormioli Pharma in EUR800 Million Deal